Literature DB >> 9928733

Survival of HIV-1 in syringes.

N Abdala1, P C Stephens, B P Griffith, R Heimer.   

Abstract

We performed a study to determine the duration of survival of HIV-1 in syringes typically used by injectors of illicit drugs (IDUs). We describe the effectiveness of a microculture assay in detecting viable virus in volumes of blood typical of those commonly found inside used syringes. Using this assay and modeling the worse-case situation for syringe sharing, we have recovered viable, proliferating HIV-1 from syringes that have been maintained at room temperature for periods in excess of 4 weeks. The percentage of syringes with viable virus varied with the volume of residual blood and the titer of HIV-1 in the blood. These experiments provide a scientific basis for needle exchange schemes, harm reduction, and other interventions among IDUs that support the nonsharing and removal of used syringes from circulation.

Entities:  

Mesh:

Year:  1999        PMID: 9928733     DOI: 10.1097/00042560-199901010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  29 in total

1.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  The beginning of a new era in understanding hepatitis C virus prevention.

Authors:  Josiah D Rich; Lynn E Taylor
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

3.  Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens.

Authors:  Michael C Clatts; Le M Giang; Lloyd A Goldsamt; Huso Yi
Journal:  Am J Prev Med       Date:  2007-06       Impact factor: 5.043

Review 4.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

5.  Increasing safe syringe collection sites in New York State.

Authors:  Susan J Klein; Alma R Candelas; Jay G Cooper; Wesley E Badillo; James M Tesoriero; Haven B Battles; Hope A Plavin
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

Review 6.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

7.  Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.

Authors:  Iuliia Makarenko; D C Ompad; Y Sazonova; T Saliuk; J DeHovitz; L Gensburg
Journal:  J Urban Health       Date:  2017-02       Impact factor: 3.671

8.  The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Authors:  August F Holtyn; Mikhail N Koffarnus; Anthony DeFulio; Sigurdur O Sigurdsson; Eric C Strain; Robert P Schwartz; Jeannie-Marie S Leoutsakos; Kenneth Silverman
Journal:  Prev Med       Date:  2014-03-04       Impact factor: 4.018

Review 9.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

10.  Statistical design for a small serial dilution series.

Authors:  Daniel Zelterman; Alexander Tulupyev; Robert Heimer; Nadia Abdala
Journal:  Stat Med       Date:  2010-02-10       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.